Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May 13;19(1):69.
doi: 10.1186/s12958-021-00757-6.

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?

Affiliations
Observational Study

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?

Raoul Orvieto et al. Reprod Biol Endocrinol. .

Abstract

Objective: No information exists in the literature regarding the effect of mRNA SARS-CoV-2 vaccine on subsequent IVF cycle attempt. We therefore aim to assess the influence of mRNA SARS-CoV-2 vaccine on IVF treatments.

Design: An observational study.

Setting: A tertiary, university-affiliated medical center.

Patients and methods: All couples undergoing consecutive ovarian stimulation cycles for IVF before and after receiving mRNA SARS-CoV-2 vaccine, and reached the ovum pick-up (OPU) stage. The stimulation characteristics and embryological variables of couples undergoing IVF treatments after receiving mRNA SARS-CoV-2 vaccine were assessed and compared to their IVF cycles prior to vaccination.

Main outcome measures: Stimulation characteristics and embryological variables.

Results: Thirty-six couples resumed IVF treatment 7-85 days after receiving mRNA SARS-CoV-2 vaccine. No in-between cycles differences were observed in ovarian stimulation and embryological variables before and after receiving mRNA SARS-CoV-2 vaccination.

Conclusions: mRNA SARS-CoV-2 vaccine did not affect patients' performance or ovarian reserve in their immediate subsequent IVF cycle. Future larger studies with longer follow-up will be needed to validate our observations.

Keywords: COVID-19; IVF; Ovarian stimulation; embryo quality; vaccination.

PubMed Disclaimer

Conflict of interest statement

Authors have nothing to declare.

Similar articles

Cited by

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. ASRM patient management and clinical recommendations during the CORONAVIRUS (COVID-19) pandemic Update No. 10 (November 17,2020). https://www.asrm.org/globalassets/asrm/asrm-content/news-andpublications....
    1. Barragan M, Guillén JJ, Martin-Palomino N, Rodriguez A, Vassena R. Undetectable viral RNA in oocytes from SARS-CoV-2 positive women. Hum Reprod Sep. 2020;30:deaa284. doi: 10.1093/humrep/deaa284. - DOI - PMC - PubMed
    1. Ruan Y, Hu B, Liu Z, Liu K, Jiang H, Li H, Li R, Luan Y, Liu X, Yu G, Xu S, Yuan X, Wang S, Yang W, Ye Z, Liu J, Wang T. (2020) No Detection of SARS-CoV-2 from Urine, Expressed Prostatic Secretions and Semen in 74 Recovered COVID-19 Male Patients: A Perspective and Urogenital Evaluation. Andrology. Nov 4. 10.1111/andr.12939. Epub ahead of print. PMID: 33150723. - PubMed
    1. Gleicher N, Barad D. Unexplained infertility: Does it really exist? Hum Reprod. 2006;21:1951–530. doi: 10.1093/humrep/del135. - DOI - PubMed

Publication types